| MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ... The Lancet Neurology 15 (3), 292-303, 2016 | 1087 | 2016 |
| Association between pathological and MRI findings in multiple sclerosis M Filippi, W Brück, D Chard, F Fazekas, JJG Geurts, C Enzinger, ... The Lancet Neurology 18 (2), 198-210, 2019 | 711 | 2019 |
| Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis MA Rocca, MP Amato, N De Stefano, C Enzinger, JJ Geurts, IK Penner, ... The Lancet Neurology 14 (3), 302-317, 2015 | 628 | 2015 |
| Cognition in multiple sclerosis: State of the field and priorities for the future JF Sumowski, R Benedict, C Enzinger, M Filippi, JJ Geurts, P Hamalainen, ... Neurology 90 (6), 278-288, 2018 | 603 | 2018 |
| MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients MP Wattjes, À Rovira, D Miller, TA Yousry, MP Sormani, N De Stefano, ... Nature Reviews Neurology 11 (10), 597-607, 2015 | 567 | 2015 |
| Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines M Filippi, P Preziosa, BL Banwell, F Barkhof, O Ciccarelli, N De Stefano, ... Brain 142 (7), 1858-1875, 2019 | 517 | 2019 |
| MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process À Rovira, MP Wattjes, M Tintoré, C Tur, TA Yousry, MP Sormani, ... Nature Reviews Neurology 11 (8), 471-482, 2015 | 502 | 2015 |
| Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis M Filippi, MA Rocca, G Martino, MA Horsfield, G Comi Annals of neurology 43 (6), 809-814, 1998 | 497 | 1998 |
| Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis M Filippi, MA Rocca, B Colombo, A Falini, M Codella, G Scotti, G Comi Neuroimage 15 (3), 559-567, 2002 | 481 | 2002 |
| 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis MP Wattjes, O Ciccarelli, DS Reich, B Banwell, N de Stefano, C Enzinger, ... The Lancet Neurology 20 (8), 653-670, 2021 | 478 | 2021 |
| MRI in multiple sclerosis: current status and future prospects R Bakshi, AJ Thompson, MA Rocca, D Pelletier, V Dousset, F Barkhof, ... The Lancet Neurology 7 (7), 615-625, 2008 | 470 | 2008 |
| Placebo-controlled trial of oral laquinimod for multiple sclerosis G Comi, D Jeffery, L Kappos, X Montalban, A Boyko, MA Rocca, M Filippi New England Journal of Medicine 366 (11), 1000-1009, 2012 | 448 | 2012 |
| Deep gray matter volume loss drives disability worsening in multiple sclerosis A Eshaghi, F Prados, WJ Brownlee, DR Altmann, C Tur, MJ Cardoso, ... Annals of neurology 83 (2), 210-222, 2018 | 430 | 2018 |
| Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study MA Rocca, A Ceccarelli, A Falini, B Colombo, P Tortorella, L Bernasconi, ... Stroke 37 (7), 1765-1770, 2006 | 416 | 2006 |
| A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis M Soilu-Hänninen, J Åivo, BM Lindström, I Elovaara, ML Sumelahti, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (5), 565-571, 2012 | 395 | 2012 |
| Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes” M Filippi, M Rovaris, MA Rocca, MP Sormani, JS Wolinsky, G Comi, ... Neurology 57 (4), 731-733, 2001 | 377 | 2001 |
| Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis M Rovaris, M Filippi, M Falautano, L Minicucci, MA Rocca, V Martinelli, ... Neurology 50 (6), 1601-1608, 1998 | 376 | 1998 |
| Default-mode network dysfunction and cognitive impairment in progressive MS MA Rocca, P Valsasina, M Absinta, G Riccitelli, ME Rodegher, P Misci, ... Neurology 74 (16), 1252-1259, 2010 | 371 | 2010 |
| Progression of regional grey matter atrophy in multiple sclerosis A Eshaghi, RV Marinescu, AL Young, NC Firth, F Prados, ... Brain 141 (6), 1665-1677, 2018 | 368 | 2018 |
| Myeloid microvesicles are a marker and therapeutic target for neuroinflammation C Verderio, L Muzio, E Turola, A Bergami, L Novellino, F Ruffini, L Riganti, ... Annals of neurology 72 (4), 610-624, 2012 | 359 | 2012 |
Massimo FilippiSan Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityVerified email at hsr.it
